Striatal dopamine transmission in healthy humans during a passive monetary reward task.
Research on dopamine (DA) transmission has emphasized the importance of increased phasic DA cell firing in the presence of unpredictable rewards. Using [(11)C]raclopride PET, we previously reported that DA transmission was both suppressed and enhanced in different regions of the striatum during an unpredictable reward task [Zald, D.H., Boileau, I., El Dearedy, W., Gunn, R., McGlone, F., Dichter, G.S. et al. (2004). Dopamine transmission in the human striatum during monetary reward tasks. J. Neurosci. 24, 4105-4112]. However, it was unclear if reductions in DA release during this task reflected a response to the high proportion of nonrewarding trials, and whether the behavioral demands of the task influenced the observed response. To test these issues, we presented 10 healthy subjects with an automated (passive) roulette wheel game in which the amount of reward and its timing were unpredictable and the rewarding trials greatly outnumbered the nonrewarding ones. As in the previous study, DA transmission in the putamen was significantly suppressed relative to a predictable control condition. A similar suppression occurred when subjects were presented with temporally unpredictable novel pictures and sounds. At present, models of DA functioning during reward do not account for this suppression, but given that it has been observed in two different studies using different reward paradigms, this phenomenon warrants attention. Neither the unpredictable reward nor the novelty conditions produced consistent increases in striatal DA transmission. These data suggest that active behavioral engagement may be necessary to observe robust statewise increases in DA release in the striatum.
Hakyemez
Hélène S
HS
McConnel Brain Imaging Center, Montreal Neurological Institute, McGill University, Montreal, Canada. helene@bic.mni.mcgill.ca
Dagher
Alain
A
Smith
Stephen D
SD
Zald
David H
DH
D000161:Acoustic Stimulation; D000328:Adult; D000339:Affect; D002421:Caudate Nucleus / Q000000981:diagnostic imaging / Q000502:physiology; D004298:Dopamine / Q000502:physiology*; D018492:Dopamine Antagonists; D007839:Functional Laterality / Q000502:physiology; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D008297:Male; D009042:Motivation; D017072:Neostriatum / Q000000981:diagnostic imaging / Q000502:physiology*; D010775:Photic Stimulation; D049268:Positron-Emission Tomography; D011699:Putamen / Q000000981:diagnostic imaging / Q000502:physiology; D020891:Raclopride; D019275:Radiopharmaceuticals; D012201:Reward; D009435:Synaptic Transmission / Q000502:physiology*
D018492:Dopamine Antagonists; D019275:Radiopharmaceuticals; D020891:Raclopride; D004298:Dopamine